| Prev Close | 36.05 |
| Open | 35.60 |
| Day Low/High | 35.45 / 36.59 |
| 52 Wk Low/High | 24.47 / 36.64 |
| Volume | 321.13K |
| Avg Volume | 295.20K |
| Exchange | NYSE |
| Shares Outstanding | 40.97M |
| Market Cap | 1.48B |
| EPS | 1.30 |
| P/E Ratio | 27.52 |
| Div & Yield | N.A. (N.A) |
Latest News
Emergent BioSolutions To Unveil Its Expanded Center For Innovation In Advanced Development And Manufacturing Supported Through Public-Private Partnership With BARDA
112,000-Square-Foot Baltimore Facility Is Designed to Enable Surge Manufacturing of Medical Countermeasures to Address Urgent Public Health Threats
EMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors Of Deadline In Class Action Lawsuit Against Emergent BioSolutions, Inc. - EBS
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Emergent Biosolutions Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 19, 2016
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Emergent Biosolutions Inc.
EBS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Emergent Biosolutions Inc. And A Lead Plaintiff Deadline Of September 19, 2016
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Maryland on behalf of investors who purchased Emergent Biosolutions Inc.
The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Emergent BioSolutions, Inc. Investors And Encourages Investors To Contact The Firm
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Emergent BioSolutions, Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Emergent Biosolutions Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 19, 2016
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Emergent Biosolutions Inc.
